Gano Kyle (CIK 1567160) reported 28 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-17). Recent activity: Sell NBIX (2,648 shares), Buy NBIX (4,907 shares), Buy NBIX (2,241 shares), Sell NBIX (1,210 shares), Buy NBIX (2,566 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Sell | 2,648 | $325,969 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Buy | 4,907 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Buy | 2,241 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Sell | 1,210 | $150,185 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Buy | 2,566 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Sell | 1,385 | $171,906 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Buy | 9,968 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Sell | 5,378 | $667,517 |
| 2026-02-03 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Buy | 2,927 | $0 |
| 2026-02-03 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Sell | 1,580 | $214,975 |
| 2026-01-20 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Buy | 1,812 | $65,214 |
| 2026-01-20 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Sell | 34,588 | $4.6M |
| 2026-01-20 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Buy | 34,588 | $1.2M |
| 2026-01-20 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Sell | 1,812 | $240,471 |
| 2025-11-04 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Buy | 613 | $0 |
| 2025-11-04 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Sell | 300 | $42,591 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Buy | 2,566 | $0 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Sell | 1,352 | $157,968 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Buy | 2,241 | $0 |
| 2025-02-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Sell | 1,206 | $140,933 |
| 2025-02-12 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Buy | 1,860 | $0 |
| 2025-02-12 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Sell | 980 | $116,022 |
| 2025-02-04 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Buy | 2,927 | $0 |
| 2025-02-04 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Sell | 1,541 | $235,573 |
| 2025-01-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer | Buy | 4,812 | $158,748 |
Source: SEC Form 4 filings · as of 2026-02-17